BIOTECHNOLOGY RESEARCH FOR NERVOUS SYSTEM DISORDERS
BIOTECHNOLOGY RESEARCH FOR NERVOUS SYSTEM DISORDERS
BIOTECHNOLOGY RESEARCH FOR NERVOUS SYSTEM DISORDERS
HUXLEY GROUP OF WORLD-CLASS PROFESSIONALS
BOARD OF DIRECTORS
Fabian Monaco is the owner of Giumar Capital Inc., a boutique investment banking and advisory practice. Mr. Monaco is also the co-founder and former CEO of Gage Growth Corp. (“Gage”), which was acquired by TerrAscend Corp. for $500M+ in 2022. Mr. Monaco, along with the co-founders, grew Gage to a $100M revenue business, operating 15+ retail locations with over 350+ employees. Mr. Monaco is also a lawyer and brings a wealth of experience in capital raising and capital markets advisory. He has held various roles in large multi-national legal firms and investment banks, specializing in M&A advisory and financing transactions.
FABIAN MONACO
Board Member
John Di Girolamo is an experienced investor and entrepreneur with over twenty years of global business experience in public and private investments. His experience includes operational management, investment banking, strategic acquisitions and investments, international business development, and merchant banking across many sectors. John is currently the Managing Partner and Chief Compliance Officer of Liberty North Capital Corporation in Toronto. More recently, he has been involved in various transactions across several sectors, helping raise capital for his clients, providing advisory services, and overseeing the structuring of mergers and acquisitions. Mr. Di Girolamo has chaired seminars in partnership with other organizations, including the Toronto Stock Exchange, educating others on how to take companies public in Canada.
JOHN DiGIROLAMO
Board Member
EXECUTIVE TEAM
GEORGE JACKOWSKI
Chief Science Officer
Dr. George Jackowski has significantly impacted the Healthcare/Biotech Sector over a 35-year career, founding 20 companies and assisting in another 10. He’s taken several of these companies to public markets in the US (NASDAQ, OTC) and Canada (TSX, CSE), creating over 1,000 high-tech jobs. His track record includes delivering valuations from tens of millions to over $350 million USD, providing seed investors with 3–10X returns within 18 months post-startup.
Dr. Jackowski has successfully cleared over 25 products through the US FDA, commercializing them globally, with revenues exceeding $10 billion USD. He has a significant track record in IP creation, patent litigation, and successful US patent issuances, with over 200 patents issued and filed. Notably, his patent for Cardiac Troponin immunoassays has generated over $500 million USD annually for over 20 years.
He co-founded a biotech company developing therapeutics against human cancer cell lines, which sold for over $190 million USD to Big Pharma. Dr. Jackowski has also completed over $100 million USD in licensing deals.Recognized for his contributions to Canadian Biotech and Pharmaceutical Industries, he received the Queen Elizabeth II Diamond Jubilee Medal and the 1996 MEDEC Award for Medical Achievement. Trained at the University of San Francisco and the University of Toronto, he has authored numerous publications and holds over 200 US patents.
SANTINO BERNAUDO
Business Development
Santino Bernaudo is a serial entrepreneur with a keen eye for identifying new growth sector opportunities. Santino excels in introducing innovation to sectors traditionally resistant to change. Santino's career is marked by a series of successful ventures, demonstrating his ability to not only envision but also actualize transformative business models. Proven track record in the areas of M&A and capital raise , product development and international market penetration experience with leading brands.